ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,376Medicare Part D Prescriptions Filled, Including Refills

Rank: 184 out of 5176

$1.38M Total Retail Price of All Prescriptions

Rank: 127 out of 5176

330 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 330 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

6% of this provider’s 330 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

0% of this provider’s 15,653 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

51% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$84 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

50 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
NEXIUM 710 699 1 16
METOPROLOL TARTRATE 460 424 2 6
METOPROLOL SUCCINATE 456 440 3 11
SIMVASTATIN 441 394 4 1
AMLODIPINE BESYLATE 429 427 5 2
CRESTOR 402 399 6 15
ZOLPIDEM TARTRATE 385 360 7 17
METFORMIN HCL 323 294 8 7
OMEPRAZOLE 299 268 9 3
PLAVIX 292 292 10 29
LOSARTAN-HYDROCHLOROTHIAZIDE 278 262 11 35
JANUVIA 260 259 12 25
LIDODERM 241 234 13 59
LOSARTAN POTASSIUM 240 228 14 14
FUROSEMIDE 235 235 15 8
HYDROCHLOROTHIAZIDE 232 222 16 10
BENICAR 226 226 17 100
GLIMEPIRIDE 226 222 17 37
LEVOTHYROXINE SODIUM 217 185 19 4
ATORVASTATIN CALCIUM 207 199 20 9
LOVAZA 202 197 21 43
CLOPIDOGREL 198 198 22 26
TAMSULOSIN HCL 197 185 23 20
CARVEDILOL 190 185 24 24
SYNTHROID 182 181 25 33
ENALAPRIL MALEATE 177 172 26 22
GABAPENTIN 168 150 27 21
DIOVAN 168 161 27 19
BYSTOLIC 164 153 29 96
LIPITOR 156 156 30 51
ADVAIR DISKUS 145 143 31 32
SPIRIVA 133 123 32 54
HYDRALAZINE HCL 131 131 33 73
DONEPEZIL HCL 131 127 33 28
ISOSORBIDE MONONITRATE ER 129 127 35 44
BENICAR HCT 126 114 36 110
TOPROL XL 121 121 37 227
TORSEMIDE 110 110 38 184
FAMOTIDINE 107 107 39 58
CREON 105 105 40 111
POTASSIUM CHLORIDE 104 95 41 34
CLONIDINE HCL 102 99 42 79
COUMADIN 97 97 43 112
LISINOPRIL 94 76 44 5
SOLARAZE 93 93 45 157
MICARDIS 91 78 46 154
ALLOPURINOL 88 88 47 41
JANUMET 84 84 48 77
DIOVAN HCT 83 83 49 39
PRAVASTATIN SODIUM 82 82 50 23
CELEBREX 81 80 51 80
PRADAXA 81 81 51 192
MECLIZINE HCL 80 80 53 81
MUPIROCIN 77 62 54 182
MICARDIS HCT 75 73 55 180
DIGOXIN 75 75 55 56
TEKTURNA 74 74 57 255
WARFARIN SODIUM 74 74 57 13
ALENDRONATE SODIUM 72 72 59 18
VESICARE 72 72 59 210
ACTOS 69 69 61 85
AMITIZA 69 69 61 197
PRAZOSIN HCL 68 68 63 527
RANITIDINE HCL 66 56 64 36
IBUPROFEN 64 47 65 72
PROCTOZONE-HC 64 64 65 171
VOLTAREN 62 60 67 97
DEXILANT 61 61 68 118
ZETIA 61 61 68 68
LANSOPRAZOLE 61 43 68 113
AVODART 56 56 71 107
GLIPIZIDE 56 56 71 63
ALCOHOL SWABS 56 52 71 115
ESCITALOPRAM OXALATE 56 56 71 89
COLCRYS 55 52 75 170
DICYCLOMINE HCL 54 54 76 224
ONGLYZA 54 54 76 153
ACETAMINOPHEN-CODEINE 54 54 S3 76 127
NITROGLYCERIN PATCH 53 53 79 149
PREDNISONE 53 52 79 52
SPIRONOLACTONE 52 52 81 88
TRIAMTERENE-HCTZ 52 33 81 86
PROAIR HFA 51 51 83 60
QUINAPRIL HCL 50 50 84 82
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 19, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.